Stock Ratings | Citizens initiated a buy recommendation for Biomea Fusion (BMEA) shares with a $9 target price (potential upside of 492.11%); Stifel raised its target price for Lumentum (LITE) shares to $1,100.
Aclaris Therapeutics, Inc. ACRS | 0.00 | |
BioMarin Pharmaceutical Inc. BMRN | 0.00 | |
PINS | 0.00 | |
Biomea Fusion Inc BMEA | 0.00 | |
InspireMD Inc. NSPR | 0.00 |
The ratings of major US investment banks are used to track the latest valuations and target prices on Wall Street daily, and to explore potential equity investment opportunities.
Risk warning:
Investing in small-cap stocks can be risky. Be prepared for potential challenges related to liquidity, high volatility, limited information, and financial instability. Always diversify your investments.
Today's key assessments and concerns
Piper Sandler: Maintaining an "overweight" rating on Aclaris Therapeutics ( Aclaris Therapeutics, Inc.(ACRS.US) ), while raising the price target from $7 to $11.
Evercore ISI Group: Maintaining its "Outperform Market" rating for BioMarin Pharmaceutical BioMarin Pharmaceutical Inc.(BMRN.US) ) stock, while raising its price target from $110 to $120.
TD Cowen: Maintaining a "buy" rating on Pinterest ( Pinterest(PINS.US) ), while raising the price target from $36 to $38.
Citizens: Biomea Fusion ( Biomea Fusion Inc(BMEA.US) ) initial rating at "outperform," with a price target of $9.
Piper Sandler: Confirming the rating on InspireMD ( InspireMD Inc.(NSPR.US) ) at "Overweight", with a price target cut from $4 to $3.
| The symbol | Classification | Target price | Current price | Percentage of potential increase/decrease | (Classification) Agency |
| Aclaris Therapeutics, Inc.(ACRS.US) | to lift | $11.0 | $4.75 | 131.58% | Piper Sandler |
| BioMarin Pharmaceutical Inc.(BMRN.US) | to lift | $120.0 | $53.24 | 125.39% | Evercore ISI Group |
| Pinterest(PINS.US) | to lift | $38.0 | $22.28 | 70.56% | TD Cowen |
| Tactile Systems Technology(TCMD.US) | to lift | $40.0 | $24.05 | 66.32% | BTIG |
| Palantir(PLTR.US) | to lift | $225.0 | $135.91 | 65.55% | Rosenblatt |
| Biomea Fusion Inc(BMEA.US) | Initial classification | $9.0 | $1.52 | 492.11% | Citizens |
| InspireMD Inc.(NSPR.US) | cut | $3.0 | $1.1 | 172.73% | Piper Sandler |
| GeneDx Holdings Corp. Class A(WGS.US) | cut | $90.0 | $34.51 | 160.79% | BTIG |
| Bob's Discount Furniture, Inc.(BOBS.US) | cut | $24.0 | $10.03 | 139.28% | UBS |
| Biohaven Ltd.(BHVN.US) | cut | $22.0 | $9.71 | 126.57% | RBC Capital |
comments:
Target price unit and current price: US Dollar;
Current price: As of the latest closing price of US stocks;
Potential percentage increase/potential decrease = (Agency target price - current price) / current price 100% (Current price = Last closing price up to the time of the count)
Lifting
Morgan Stanley: Maintaining an "overweight" rating on Applied Materials ( Applied Materials, Inc.(AMAT.US) ) stock, while raising the price target from $432 to $454.
Argus Research: Maintaining a "buy" rating on Caterpillar Caterpillar Inc.(CAT.US) ) stock, while raising its price target from $820 to $990.
Wells Fargo: Maintaining an "overweight" rating on Circle Internet Group ( Circle(CRCL.US) ), while raising its price target from $111 to $142.
Wells Fargo: Maintaining an "overweight" rating on CrowdStrike Holdings CrowdStrike(CRWD.US) , while raising its price target from $450 to $525.
Jefferies: Maintaining a "buy" rating on CoreWeave ( CoreWeave(CRWV.US) ), while raising the price target from $120 to $160.
Stifel: Maintaining a "buy" rating on Lumentum Holdings Lumentum Holdings, Inc.(LITE.US) , while raising the price target from $800 to $1100.
Barclays: Maintaining an "overweight" rating on Eli Lilly ( Eli Lilly and Company(LLY.US) ), while raising its price target from $1,350 to $1,400.
First Coverage
Seaport Global: Initial rating for Applied Materials ( Applied Materials, Inc.(AMAT.US) at "buy", with a target price of $500.
UBS: Kaiser Aluminum ( Kaiser Aluminum Corporation(KALU.US) ) has a preliminary rating of "neutral" with a price target of $176.
Seaport Global: Initial rating for Lam Research Lam Research Corporation(LRCX.US) ) stock at "buy", with a target price of $300.
Cantor Fitzgerald: Initial rating for Energy Vault ( Energy Vault(NRGV.US) ) at "overweight", with a price target of $7.
reduction
UBS: Maintaining a "buy" rating on AppLovin ( AppLovin(APP.US) ), while lowering the price target from $740 to $716.
DA Davidson: Maintaining a "neutral" rating on Palantir Technologies Palantir(PLTR.US) stock, while lowering the price target from $180 to $165.
Canaccord Genuity: Maintaining a "Buy" rating on GeneDx Holdings ( GeneDx Holdings Corp. Class A(WGS.US) ), while lowering the target price from $100 to $75.
Mizuho: Maintains Willis Towers Watson's ( Willis Towers Watson(WTW.US) ) rating at "Outperform Market," while lowering its price target from $353 to $338.
Editor's Note: This content was created by Saham's AI-powered SaaS tool and reviewed by our editorial team.
Risk Warning: Investing involves risk. Securities may rise, fall, or become worthless. Investing does not guarantee profits and may result in losses. Past performance is not necessarily indicative of future results. Before making any investment decision, investors should assess their financial situation, investment objectives, experience, risk tolerance, and understand the nature of the investment products and their associated risks. For more details on the nature and risks of each investment product, please read the relevant offering documents carefully. If you have any questions, it is advisable to seek independent professional advice.